论文部分内容阅读
肝硬化患者纤溶系统活性增强常常是引起临床出血的主要原因之一,也是肝功能受损的重要标志之一。本文检测肝硬化患者血浆D-二聚体及纤溶酶原活性变化,以探讨肝硬化患者外周血纤溶紊乱发生的某些机制及检测指标的临床意义。 1 对象 肝硬化患者53例,均为我院消化科门诊及住院病人。诊断符合1995年北京第五次全国传染病寄生虫病学术会议修订的标准。其中男性38例,女性15例,年龄15～76岁;代偿期患者
Fibrinolytic system activity in patients with cirrhosis is often one of the main causes of clinical bleeding, but also one of the important signs of impaired liver function. This article examines the changes of plasma D-dimer and plasminogen activity in patients with cirrhosis, in order to investigate the clinical significance of some mechanism of fibrinolytic disorder in peripheral blood of patients with cirrhosis and detection index. 1 patients with liver cirrhosis in 53 cases, all of our hospital gastroenterology outpatient and inpatient. Diagnosis in line with the 1995 Beijing Fifth National Conference on Infectious Diseases parasitic disease revised standards. Among them, 38 were males and 15 were females, aged 15-76 years. Patients with compensated disease